133 related articles for article (PubMed ID: 7525807)
1. [Malignant lymphoma].
Hirano M
Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):363-7. PubMed ID: 7525807
[No Abstract] [Full Text] [Related]
2. Hodgkin's lymphoma--the great teacher.
Connors JM
N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
[No Abstract] [Full Text] [Related]
3. [Treatment of malignant lymphoma in childhood].
Hattori T; Ishikawa Y; Nishi M; Nakadate H; Hatae Y; Takeda T
Rinsho Ketsueki; 1985 Jan; 26(1):1-6. PubMed ID: 2582160
[No Abstract] [Full Text] [Related]
4. European experience with ifosfamide in lymphomas.
von Kalle AK; Schaadt M; Diehl V
Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
[TBL] [Abstract][Full Text] [Related]
5. Cure in a case of primary hepatic lymphoma.
Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
[TBL] [Abstract][Full Text] [Related]
6. Primary colorectal T-cell lymphoma.
Okada M; Maeda K; Suzumiya J; Hagimoto T; Wakamatsu S; Ohshima K; Kanda M; Sonoda T; Sakamoto A; Tamura K
J Gastroenterol; 2003; 38(4):376-84. PubMed ID: 12743779
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
Ai Zheng; 2006 Apr; 25(4):471-5. PubMed ID: 16613683
[TBL] [Abstract][Full Text] [Related]
9. Multiple cutaneous relapses in an adolescent in anaplastic large cell lymphoma diagnosed by FNAC.
Mandal S; Varma K; Jain S
Cytopathology; 2008 Apr; 19(2):127-9. PubMed ID: 18070116
[No Abstract] [Full Text] [Related]
10. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
11. Gall bladder perforation in response to chemotherapy in a patient with a histiocytic lymphoma.
Schaafsma MR; Peters WG; Tham RT; Alleman MJ; Willemze R
Neth J Med; 1988 Aug; 33(1-2):78-82. PubMed ID: 2469970
[No Abstract] [Full Text] [Related]
12. CHOP therapy: has shorter-course therapy had an impact on lymphomas?
Gaynor ER; Fisher RI
Cancer Invest; 1998; 16(1):26-32. PubMed ID: 9474248
[No Abstract] [Full Text] [Related]
13. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
14. [Bilateral highly malignant centroblastic lymphoma of the breast].
Hering M; Hagel E; Zwicker C; Krieger G
Rofo; 1996 Aug; 165(2):198-200. PubMed ID: 8924675
[No Abstract] [Full Text] [Related]
15. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Klastersky J
Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
[No Abstract] [Full Text] [Related]
16. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
17. [NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Kohda K; Tsuji A; Takayanagi N; Takeda M; Hayashi S; Takimoto R; Fujisaki Y; Tsuji Y; Ezoe A; Nakazawa O
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2183-9. PubMed ID: 7694548
[TBL] [Abstract][Full Text] [Related]
18. [Nutritional support in non-Hodgkin's lymphoma treated with polychemotherapy MACOP-B cycle].
Boggio Bertinet D; Pezzana A; Vitolo U; Bertini M; Xompero G; Palmo A; Balzola F
Minerva Gastroenterol Dietol; 1991; 37(2):117-21. PubMed ID: 1720675
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
20. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]